PDI, Inc. acquires RedPath Integrated Pathology, Inc.

On November 3, 2014, PDI, Inc. acquired RedPath Integrated Pathology, Inc., a life science company in Pennsylvania, United States, from NewSpring Capital.

Deal at a glance

AnnouncedNovember 3, 2014 TypeAdd-on Acquistion TargetRedPath Integrated Pathology, Inc. Buyer PDI, Inc. Seller NewSpring Capital SectorLife Science LocationPennsylvania, United States ValueNot disclosed

Target company

RedPath Integrated Pathology, Inc.

Pennsylvania, United States

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

PDI, Inc.

Company · 2 deals on record

1st transaction in life science
2nd transaction in United States

2deals, all time

1in this sector

2014latest

Seller

NewSpring Capital

Private equity firm · 175 deals on record

175investments

10in this sector

63exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Frontier Technology LLC (MicroAge)Same seller · Sep 2026

TenFourSame seller · Mar 2022

Radius Global Market ResearchSame seller · Feb 2022

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired RedPath Integrated Pathology, Inc.?PDI, Inc. acquired RedPath Integrated Pathology, Inc. on November 3, 2014.

Who sold RedPath Integrated Pathology, Inc.?NewSpring Capital was the seller.

What type of deal was it?It was a add-on acquistion in the life science sector in 2014.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).